GILEAD SCIENCES INC (GILD) Stock Fundamental Analysis

NASDAQ:GILD • US3755581036

147.83 USD
-2.2 (-1.47%)
At close: Mar 3, 2026
147.83 USD
0 (0%)
After Hours: 3/3/2026, 4:20:00 PM
Fundamental Rating

7

GILD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 520 industry peers in the Biotechnology industry. While GILD has a great profitability rating, there are some minor concerns on its financial health. GILD is not valued too expensively and it also shows a decent growth rate. GILD also has an excellent dividend rating. With these ratings, GILD could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • GILD had positive earnings in the past year.
  • GILD had a positive operating cash flow in the past year.
  • In the past 5 years GILD has always been profitable.
  • In the past 5 years GILD always reported a positive cash flow from operatings.
GILD Yearly Net Income VS EBIT VS OCF VS FCFGILD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • The Return On Assets of GILD (14.42%) is better than 95.19% of its industry peers.
  • GILD has a Return On Equity of 37.49%. This is amongst the best in the industry. GILD outperforms 98.08% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 19.49%, GILD belongs to the top of the industry, outperforming 97.50% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for GILD is in line with the industry average of 18.99%.
  • The last Return On Invested Capital (19.49%) for GILD is above the 3 year average (17.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROIC 19.49%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
GILD Yearly ROA, ROE, ROICGILD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • GILD has a better Profit Margin (28.90%) than 95.38% of its industry peers.
  • In the last couple of years the Profit Margin of GILD has grown nicely.
  • GILD has a Operating Margin of 39.98%. This is amongst the best in the industry. GILD outperforms 98.46% of its industry peers.
  • GILD's Operating Margin has been stable in the last couple of years.
  • GILD has a better Gross Margin (78.83%) than 84.81% of its industry peers.
  • In the last couple of years the Gross Margin of GILD has remained more or less at the same level.
Industry RankSector Rank
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GILD Yearly Profit, Operating, Gross MarginsGILD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GILD is creating value.
  • GILD has less shares outstanding than it did 1 year ago.
  • GILD has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, GILD has an improved debt to assets ratio.
GILD Yearly Shares OutstandingGILD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GILD Yearly Total Debt VS Total AssetsGILD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • GILD has an Altman-Z score of 4.69. This indicates that GILD is financially healthy and has little risk of bankruptcy at the moment.
  • GILD has a better Altman-Z score (4.69) than 71.92% of its industry peers.
  • The Debt to FCF ratio of GILD is 2.64, which is a good value as it means it would take GILD, 2.64 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of GILD (2.64) is better than 92.88% of its industry peers.
  • GILD has a Debt/Equity ratio of 0.97. This is a neutral value indicating GILD is somewhat dependend on debt financing.
  • GILD has a Debt to Equity ratio of 0.97. This is in the lower half of the industry: GILD underperforms 74.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Altman-Z 4.69
ROIC/WACC2.44
WACC8%
GILD Yearly LT Debt VS Equity VS FCFGILD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • GILD has a Current Ratio of 1.55. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of GILD (1.55) is worse than 80.38% of its industry peers.
  • GILD has a Quick Ratio of 1.40. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.40, GILD is doing worse than 80.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.4
GILD Yearly Current Assets VS Current LiabilitesGILD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.79% over the past year.
  • The Earnings Per Share has been growing slightly by 2.83% on average over the past years.
  • The Revenue has been growing slightly by 2.40% in the past year.
  • Measured over the past years, GILD shows a small growth in Revenue. The Revenue has been growing by 3.58% on average per year.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.47% on average over the next years. This is quite good.
  • GILD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.32% yearly.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GILD Yearly Revenue VS EstimatesGILD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GILD Yearly EPS VS EstimatesGILD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

  • GILD is valuated rather expensively with a Price/Earnings ratio of 18.14.
  • GILD's Price/Earnings ratio is rather cheap when compared to the industry. GILD is cheaper than 93.85% of the companies in the same industry.
  • GILD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.13.
  • With a Price/Forward Earnings ratio of 16.57, GILD is valued correctly.
  • Based on the Price/Forward Earnings ratio, GILD is valued cheaply inside the industry as 95.77% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.11, GILD is valued a bit cheaper.
Industry RankSector Rank
PE 18.14
Fwd PE 16.57
GILD Price Earnings VS Forward Price EarningsGILD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GILD is valued cheaper than 95.19% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, GILD is valued cheaply inside the industry as 95.96% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.4
EV/EBITDA 13.79
GILD Per share dataGILD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GILD does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of GILD may justify a higher PE ratio.
PEG (NY)1.92
PEG (5Y)6.42
EPS Next 2Y8.64%
EPS Next 3Y8.05%

7

5. Dividend

5.1 Amount

  • GILD has a Yearly Dividend Yield of 2.28%.
  • Compared to an average industry Dividend Yield of 1.19, GILD pays a better dividend. On top of this GILD pays more dividend than 98.46% of the companies listed in the same industry.
  • GILD's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.28%

5.2 History

  • The dividend of GILD has a limited annual growth rate of 3.30%.
  • GILD has paid a dividend for at least 10 years, which is a reliable track record.
  • GILD has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)3.3%
Div Incr Years9
Div Non Decr Years9
GILD Yearly Dividends per shareGILD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 47.04% of the earnings are spent on dividend by GILD. This is a bit on the high side, but may be sustainable.
  • The dividend of GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP47.04%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
GILD Yearly Income VS Free CF VS DividendGILD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GILD Dividend Payout.GILD Dividend Payout, showing the Payout Ratio.GILD Dividend Payout.PayoutRetained Earnings

GILEAD SCIENCES INC

NASDAQ:GILD (3/3/2026, 4:20:00 PM)

After market: 147.83 0 (0%)

147.83

-2.2 (-1.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner Change0.54%
Ins Owners0.07%
Ins Owner Change0.59%
Market Cap183.41B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.62
Price Target159.01 (7.56%)
Short Float %1.77%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 2.28%
Yearly Dividend3.22
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)15.95%
PT rev (3m)19%
EPS NQ rev (1m)-7.95%
EPS NQ rev (3m)-7.15%
EPS NY rev (1m)-0.14%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 18.14
Fwd PE 16.57
P/S 6.23
P/FCF 19.4
P/OCF 18.31
P/B 8.08
P/tB N/A
EV/EBITDA 13.79
EPS(TTM)8.15
EY5.51%
EPS(NY)8.92
Fwd EY6.03%
FCF(TTM)7.62
FCFY5.16%
OCF(TTM)8.07
OCFY5.46%
SpS23.73
BVpS18.3
TBVpS-2.09
PEG (NY)1.92
PEG (5Y)6.42
Graham Number57.93
Profitability
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROCE 24.94%
ROIC 19.49%
ROICexc 25.18%
ROICexgc 81.81%
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
FCFM 32.11%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Debt/EBITDA 1.52
Cap/Depr 20.4%
Cap/Sales 1.91%
Interest Coverage 11.36
Cash Conversion 68.94%
Profit Quality 111.11%
Current Ratio 1.55
Quick Ratio 1.4
Altman-Z 4.69
F-Score8
WACC8%
ROIC/WACC2.44
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year18.57%
EBIT Next 3Y11.36%
EBIT Next 5Y8.77%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%

GILEAD SCIENCES INC / GILD FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (GILD) stock?

ChartMill assigns a fundamental rating of 7 / 10 to GILD.


What is the valuation status for GILD stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GILD). This can be considered as Fairly Valued.


How profitable is GILEAD SCIENCES INC (GILD) stock?

GILEAD SCIENCES INC (GILD) has a profitability rating of 9 / 10.


What is the valuation of GILEAD SCIENCES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (GILD) is 18.14 and the Price/Book (PB) ratio is 8.08.


How sustainable is the dividend of GILEAD SCIENCES INC (GILD) stock?

The dividend rating of GILEAD SCIENCES INC (GILD) is 7 / 10 and the dividend payout ratio is 47.04%.